Cap displayed in your preferred currency (USD)
Industries & Sectors
| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| North America (Primary) | PRIMARYNOAM | Univ | 8,145 | 59,660,955 | 0.15% | 1.60% | 6.01% | 6.51% | 16.95% | 26.43% |
| Healthcare | HEALTHCARE | Sector | 1,333 | 6,612,544 | 0.02% | 1.84% | 6.01% | 1.11% | 14.01% | 14.79% |
| Biopharmaceuticals | BIOPHARMA | SubSec | 675 | 3,052,063 | -0.14% | 2.02% | 4.26% | -1.18% | 23.58% | 30.63% |
| System-Specific Biopharmaceuticals | BIOPHARMASYS | Industry | 308 | 1,574,549 | 0.13% | 2.15% | 4.25% | 0.24% | 22.96% | 18.88% |
| Digestive System Biopharmaceuticals | DIGESTIVE | SubInd | 30 | 27,690 | -1.64% | 0.60% | 4.46% | -0.31% | 31.01% | -0.05% |
Show Stocks
Sort: 3Mo %
| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| Viking Therapeutics, Inc. | VKTX:USAVKTX:USA | Stock | 1 | 7,385 | -2.98% | -9.02% | 3.60% | 87.47% | 536.28% | 189.04% |
| Spyre Therapeutics, Inc. | SYRE:USASYRE:USA | Stock | 1 | 1,385 | 0.00% | 2.36% | 6.24% | 72.21% | 278.38% | 929.27% |
| Wave Life Sciences Ltd. | WVE:USAWVE:USA | Stock | 1 | 766 | 6.10% | 11.39% | 30.42% | 52.31% | 14.03% | 75.84% |
| S&P 500 | SPY:USASPY:USA | Benchmark | 14,703 | 77,878,209 | 0.14% | 1.65% | 5.99% | 6.91% | 18.44% | 28.12% |
| Phathom Pharmaceuticals, Inc. | PHAT:USAPHAT:USA | Stock | 1 | 617 | -1.40% | 10.66% | 11.18% | 3.64% | 43.79% | -18.55% |
| Arbutus Biopharma Corp. | ABUS:USAABUS:USA | Stock | 1 | 537 | 3.11% | 3.47% | 9.16% | 3.47% | 61.08% | 19.20% |
| Digestive System Biopharmaceuticals | DIGESTIVE | SubInd | 30 | 27,690 | -1.64% | 0.60% | 4.46% | -0.31% | 31.01% | -0.05% |
| Madrigal Pharmaceuticals, Inc. | MDGL:USAMDGL:USA | Stock | 1 | 4,374 | 1.33% | 7.22% | -0.99% | -4.20% | 30.45% | -20.41% |
| Akero Therapeutics, Inc. | AKRO:USAAKRO:USA | Stock | 1 | 1,377 | -3.91% | 1.37% | -2.88% | -7.86% | 37.95% | -56.32% |
| Ardelyx, Inc. | ARDX:USAARDX:USA | Stock | 1 | 1,827 | 0.26% | 0.51% | 21.27% | -8.65% | 93.80% | 114.56% |
| Arrowhead Pharmaceuticals, Inc. | ARWR:USAARWR:USA | Stock | 1 | 3,075 | -0.92% | 12.18% | 9.55% | -15.23% | -4.95% | -31.73% |
| Mirum Pharmaceuticals, Inc. | MIRM:USAMIRM:USA | Stock | 1 | 1,133 | -2.75% | -2.79% | 2.12% | -17.26% | -20.59% | -7.60% |
| Morphic Holding, Inc. | MORF:USAMORF:USA | Stock | 1 | 1,464 | -9.92% | 2.13% | 6.25% | -18.62% | 26.48% | -48.37% |
| Verve Therapeutics, Inc. | VERV:USAVERV:USA | Stock | 1 | 501 | -6.27% | -0.50% | -10.21% | -54.21% | -45.54% | -63.40% |
| Ironwood Pharmaceuticals, Inc. | IRWD:USAIRWD:USA | Stock | 1 | 1,030 | -2.41% | -7.43% | -14.74% | -56.30% | -31.36% | -36.59% |
* Colors indicate performance relative to the benchmark.